Was The FDA Too Slow To React To New Jersey Pharmaceutical Company Distributing Allegedly Contaminated Products?
The FDA announced that on October 2, 2014, a complaint was filed in the U.S. District Court for the District of New Jersey, seeking a permanent injunction to stop Pharmaceutical Innovations Inc., a New Jersey pharmaceutical that manufactures and distributes ultrasound, mammography, and electro[...]